Of the 8 individuals which possessed the heterozygous alleles and displayed elevated DNA damage, 6 were pancreatic cancer cases and 2 were healthy related control subjects (Table 6), suggesting that the increased DNA damage observed in the ERCC4 R415Q heterozygotes contributes to development of pancreatic cancer. Here, ERCC4 is linked to pancreatic neoplasm.